![Gary Gemignani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Gemignani
Finanzdirektor/CFO bei
Solta Medical, Inc.
Profil
Gary G.
Gemignani currently works at Algorithm Sciences, Inc., as Director from 2021, Laidlaw Venture Partners, as Director from 2021, and Solta Medical, Inc., as Chief Financial Officer & EVP from 2022.
Mr. Gemignani also formerly worked at IASO Pharma, Inc., as Director from 2010 to 2012, Bluejay Diagnostics, Inc., as Independent Director, Gentium Srl, as Chief Financial Officer & Executive Vice President, Biodel, Inc., as Chief Financial Officer from 2014 to 2016, Fortress Biotech, Inc., as Executive VP, Chief Operating & Financial Officer from 2010 to 2011, Champions Oncology, Inc., as Chief Financial Officer & Executive Vice President from 2011 to 2013, Synergy Pharmaceuticals LLC, as Chief Financial Officer & Executive Vice President from 2017 to 2019, Acacia Pharma Group Ltd., as Chief Financial Officer & Executive Vice President from 2020 to 2022, and Albireo Pharma, Inc., as Chief Financial Officer.
Mr. Gemignani received his undergraduate degree in 1987 from Saint Peter's University.
Aktive Positionen von Gary Gemignani
| Unternehmen | Position | Beginn |
|---|---|---|
Laidlaw Private Equity, LLC
 Laidlaw Private Equity, LLC Investment ManagersFinance Laidlaw Venture invests in companies located in the United States. The firm targets companies operating in a broad range of sectors and industries. It provides financing for early stage capital requirements. | Direktor/Vorstandsmitglied | 04.10.2021 |
Algorithm Sciences, Inc.
 Algorithm Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company specializing in pulmonary arterial hypertension | Direktor/Vorstandsmitglied | 04.10.2021 |
Solta Medical, Inc.
 Solta Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes aesthetics technologies for skin tightening | Finanzdirektor/CFO | 01.01.2022 |
Ehemalige bekannte Positionen von Gary Gemignani
| Unternehmen | Position | Ende |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Finanzdirektor/CFO | 23.03.2022 |
| SYNERGY PHARMACEUTICALS INC | Finanzdirektor/CFO | 01.07.2019 |
| CHAMPIONS ONCOLOGY, INC. | Finanzdirektor/CFO | 30.06.2013 |
| FORTRESS BIOTECH, INC. | Finanzdirektor/CFO | 26.09.2011 |
| GENTIUM S.P.A. (ADR) | Finanzdirektor/CFO | 31.03.2010 |
Ausbildung von Gary Gemignani
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
47
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Gentium Srl
 Gentium Srl Pharmaceuticals: MajorHealth Technology Manufactures and develops biopharmaceutical products for cancer treatments & vascular diseases | Health Technology |
Biodel, Inc.
 Biodel, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
IASO Pharma, Inc.
 IASO Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products | Health Technology |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
Saint Peter's University
 Saint Peter's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Champions Oncology, Inc.
 Champions Oncology, Inc. BiotechnologyHealth Technology Provides advanced technology solutions and services for oncology drugs | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
Solta Medical, Inc.
Solta Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes aesthetics technologies for skin tightening | Health Technology |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Bluejay Diagnostics, Inc.
 Bluejay Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets non-invasive, point-of-care tests and devices | Health Technology |
Algorithm Sciences, Inc.
Algorithm Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company specializing in pulmonary arterial hypertension | Health Technology |
Laidlaw Private Equity, LLC
Laidlaw Private Equity, LLC Investment ManagersFinance Laidlaw Venture invests in companies located in the United States. The firm targets companies operating in a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
